We are live on ! Find out more
ASXC

Asensus Surgical, Inc.

Delisted

ASXC was delisted on the 21st of August, 2024.

141 hedge funds and large institutions have $92.3M invested in Asensus Surgical, Inc. in 2019 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 45 increasing their positions, 31 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 31

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

5% less funds holding

Funds holding: 149141 (-8)

21% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 24

45% less call options, than puts

Call options by funds: $1.32M | Put options by funds: $2.41M

47% less capital invested

Capital invested by funds: $174M → $92.3M (-$81.5M)

Holders
141
Holders Change
-8
Holders Change %
-5.37%
% of All Funds
3.06%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
19
Increased
45
Reduced
31
Closed
24
Calls
$1.32M
Puts
$2.41M
Net Calls
-$1.09M
Net Calls Change
+$1.9M

ASXC Hedge Fund Activity: Q2 2019 in Review

141 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Asensus Surgical, Inc. (ASXC) for Q2 2019, worth a combined $92.3M — down 47% from $174M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of ASXC and 19 opened new positions — a net loss of 5 holders — while 31 trimmed existing stakes and 45 added.

The largest buyer was Masters Capital Management, adding an estimated $3.89M. The largest seller was JP Morgan Chase, cutting an estimated $10.8M.

  • 141 institutional investors held Asensus Surgical, Inc. (ASXC) as of Q2 2019, down from 149 in Q1 2019.
  • Funds reported $92.3M of Asensus Surgical, Inc. stock for Q2 2019, down 47% quarter-over-quarter.
  • 19 funds opened new Asensus Surgical, Inc. positions in Q2 2019 and 24 closed out, a net change of -5 holders.
  • The largest Asensus Surgical, Inc. buyer in Q2 2019 was Masters Capital Management, an estimated $3.89M added.
  • The largest Asensus Surgical, Inc. seller in Q2 2019 was JP Morgan Chase, an estimated $10.8M sold.

Based on aggregated 13F filings for Q2 2019.